Identifying a new biomarker for painful nerve damage
Discovery and Validation of a Novel Response Biomarker Signature for Painful Peripheral Neuropathy
This study is looking for a new way to measure ongoing nerve pain in people with peripheral neuropathy, so we can find better treatments that really work for you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Lasmed, LLC NIH-funded |
| Lab location | 1 site (Mountain View, United States) |
| Project ID | NIH-10917059 on NIH RePORTER |
What this research studies
This research aims to discover and validate a new biomarker signature that can indicate ongoing neuropathic pain in patients. By using a specialized technique to stimulate nerve fibers, the study will assess how these fibers respond to pain, which could lead to better-targeted pain therapies. The goal is to create a reliable biomarker that can help evaluate the effectiveness of treatments for painful peripheral neuropathy, a condition that significantly affects many individuals' quality of life. Patients participating in this research may undergo assessments that involve measuring their nerve responses to specific stimuli.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing ongoing neuropathic pain due to conditions like diabetes, chemotherapy, or other causes.
Not a fit: Patients with neuropathic pain that is not ongoing or those who do not have a diagnosis related to peripheral neuropathy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for patients suffering from painful peripheral neuropathy.
How similar studies have performed: Previous research has shown promise in identifying biomarkers for pain, but this specific approach is novel and has not been extensively tested.
Where this research is happening
Mountain View, United States
- Lasmed, LLC — Mountain View, United States (Active)
Researchers
- Principal investigator: Nemenov, Mikhail I. — Lasmed, LLC
- Study coordinator: Nemenov, Mikhail I.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.